Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?
Ontology highlight
SUBMITTER: Roviello G
PROVIDER: S-EPMC8273868 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA